![JCM | Free Full-Text | Hypertension, Thrombosis, Kidney Failure, and Diabetes: Is COVID-19 an Endothelial Disease? A Comprehensive Evaluation of Clinical and Basic Evidence JCM | Free Full-Text | Hypertension, Thrombosis, Kidney Failure, and Diabetes: Is COVID-19 an Endothelial Disease? A Comprehensive Evaluation of Clinical and Basic Evidence](https://pub.mdpi-res.com/jcm/jcm-09-01417/article_deploy/html/images/jcm-09-01417-g001.png?1589172302)
JCM | Free Full-Text | Hypertension, Thrombosis, Kidney Failure, and Diabetes: Is COVID-19 an Endothelial Disease? A Comprehensive Evaluation of Clinical and Basic Evidence
![Frontiers | Pathophysiological Processes Underlying the High Prevalence of Deep Vein Thrombosis in Critically Ill COVID-19 Patients Frontiers | Pathophysiological Processes Underlying the High Prevalence of Deep Vein Thrombosis in Critically Ill COVID-19 Patients](https://www.frontiersin.org/files/Articles/608788/fphys-11-608788-HTML-r1/image_m/fphys-11-608788-g001.jpg)
Frontiers | Pathophysiological Processes Underlying the High Prevalence of Deep Vein Thrombosis in Critically Ill COVID-19 Patients
![Styracifoline from the Vietnamese Plant Desmodium styracifolium: A Potential Inhibitor of Diabetes-Related and Thrombosis-Based Proteins | ACS Omega Styracifoline from the Vietnamese Plant Desmodium styracifolium: A Potential Inhibitor of Diabetes-Related and Thrombosis-Based Proteins | ACS Omega](https://pubs.acs.org/cms/10.1021/acsomega.1c02840/asset/images/large/ao1c02840_0008.jpeg)
Styracifoline from the Vietnamese Plant Desmodium styracifolium: A Potential Inhibitor of Diabetes-Related and Thrombosis-Based Proteins | ACS Omega
![Thromboembolism risk of COVID-19 is high and associated with a higher risk of mortality: A systematic review and meta-analysis - eClinicalMedicine Thromboembolism risk of COVID-19 is high and associated with a higher risk of mortality: A systematic review and meta-analysis - eClinicalMedicine](https://www.thelancet.com/cms/asset/39a86a18-e0ed-4f56-a821-89a526112de7/gr1.jpg)
Thromboembolism risk of COVID-19 is high and associated with a higher risk of mortality: A systematic review and meta-analysis - eClinicalMedicine
![Prevention of atherothrombotic events in patients with diabetes mellitus: from antithrombotic therapies to new-generation glucose-lowering drugs | Nature Reviews Cardiology Prevention of atherothrombotic events in patients with diabetes mellitus: from antithrombotic therapies to new-generation glucose-lowering drugs | Nature Reviews Cardiology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41569-018-0080-2/MediaObjects/41569_2018_80_Fig1_HTML.png)
Prevention of atherothrombotic events in patients with diabetes mellitus: from antithrombotic therapies to new-generation glucose-lowering drugs | Nature Reviews Cardiology
![Frontiers | Thrombosis and Vascular Inflammation in Diabetes: Mechanisms and Potential Therapeutic Targets Frontiers | Thrombosis and Vascular Inflammation in Diabetes: Mechanisms and Potential Therapeutic Targets](https://www.frontiersin.org/files/Articles/325956/fcvm-05-00001-HTML/image_m/fcvm-05-00001-g003.jpg)
Frontiers | Thrombosis and Vascular Inflammation in Diabetes: Mechanisms and Potential Therapeutic Targets
![MANAGEMENT OF ENDOCRINE DISEASE: Cardiovascular risk assessment, thromboembolism, and infection prevention in Cushing's syndrome: a practical approach in: European Journal of Endocrinology Volume 184 Issue 5 (2021) MANAGEMENT OF ENDOCRINE DISEASE: Cardiovascular risk assessment, thromboembolism, and infection prevention in Cushing's syndrome: a practical approach in: European Journal of Endocrinology Volume 184 Issue 5 (2021)](https://eje.bioscientifica.com/view/journals/eje/184/5/images/EJE-20-1309fig1.jpeg)
MANAGEMENT OF ENDOCRINE DISEASE: Cardiovascular risk assessment, thromboembolism, and infection prevention in Cushing's syndrome: a practical approach in: European Journal of Endocrinology Volume 184 Issue 5 (2021)
![Frontiers | Thrombosis and Vascular Inflammation in Diabetes: Mechanisms and Potential Therapeutic Targets Frontiers | Thrombosis and Vascular Inflammation in Diabetes: Mechanisms and Potential Therapeutic Targets](https://www.frontiersin.org/files/Articles/325956/fcvm-05-00001-HTML/image_m/fcvm-05-00001-g001.jpg)
Frontiers | Thrombosis and Vascular Inflammation in Diabetes: Mechanisms and Potential Therapeutic Targets
![Mechanistic pathways for increased thrombosis risk in diabetes. The... | Download Scientific Diagram Mechanistic pathways for increased thrombosis risk in diabetes. The... | Download Scientific Diagram](https://www.researchgate.net/publication/322599193/figure/fig2/AS:584536534564871@1516375778979/Mechanistic-pathways-for-increased-thrombosis-risk-in-diabetes-The-metabolic-changes.png)
Mechanistic pathways for increased thrombosis risk in diabetes. The... | Download Scientific Diagram
![N-acetylcysteine attenuates systemic platelet activation and cerebral vessel thrombosis in diabetes. - Abstract - Europe PMC N-acetylcysteine attenuates systemic platelet activation and cerebral vessel thrombosis in diabetes. - Abstract - Europe PMC](https://europepmc.org/articles/PMC5619994/bin/fx1.jpg)
N-acetylcysteine attenuates systemic platelet activation and cerebral vessel thrombosis in diabetes. - Abstract - Europe PMC
![The potential synergistic effect of anti-diabetic and anti-platelet... | Download Scientific Diagram The potential synergistic effect of anti-diabetic and anti-platelet... | Download Scientific Diagram](https://www.researchgate.net/publication/351526892/figure/fig1/AS:1024715384696835@1621322594790/The-potential-synergistic-effect-of-anti-diabetic-and-anti-platelet-agents-on_Q640.jpg)
The potential synergistic effect of anti-diabetic and anti-platelet... | Download Scientific Diagram
![Interplay between inflammation and thrombosis in cardiovascular pathology | Nature Reviews Cardiology Interplay between inflammation and thrombosis in cardiovascular pathology | Nature Reviews Cardiology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41569-021-00552-1/MediaObjects/41569_2021_552_Fig1_HTML.png)
Interplay between inflammation and thrombosis in cardiovascular pathology | Nature Reviews Cardiology
![Hypofibrinolysis in diabetes: a therapeutic target for the reduction of cardiovascular risk | Cardiovascular Diabetology | Full Text Hypofibrinolysis in diabetes: a therapeutic target for the reduction of cardiovascular risk | Cardiovascular Diabetology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12933-017-0515-9/MediaObjects/12933_2017_515_Fig2_HTML.gif)
Hypofibrinolysis in diabetes: a therapeutic target for the reduction of cardiovascular risk | Cardiovascular Diabetology | Full Text
![Endothelial dysfunction and platelet hyperactivity in type 2 diabetes mellitus: molecular insights and therapeutic strategies | Cardiovascular Diabetology | Full Text Endothelial dysfunction and platelet hyperactivity in type 2 diabetes mellitus: molecular insights and therapeutic strategies | Cardiovascular Diabetology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12933-018-0763-3/MediaObjects/12933_2018_763_Fig1_HTML.png)